Hi Wayne, yes indeed. Looks like everything is ticking along nicely for Phylogica's in-house programs. CD40 ligand program appears to be most advanced. Fully optimized leads ready to go pre-clinical. And yes, it seems they're progressing antibiotic to Acinetobacter. Their intracellular lead program against sonic hedgehog pathway for cancer is one to keep an eye on imo.
Hi Wayne, yes indeed. Looks like everything is ticking along...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.42 | $3.475M | 2.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55564 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 6099 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |